Lutetium [177Lu] oxodotreotide/dotatate: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase breakdown

Not applicable 1

Condition	Trials
Digestive System Diseases	1
Digestive System Neoplasms	1
Endocrine Gland Neoplasms	1
Endocrine System Diseases	1
Gastrointestinal Disease	1
Gastrointestinal Neoplasms	1
Intestinal Diseases	1
Intestinal Neoplasms	1
Neoplasms	1
Neoplasms by Histologic Type	1
Neoplasms by Site	1
Neoplasms, Germ Cell and Embryonal	1
Neoplasms, Nerve Tissue	1
Neuroectodermal Tumors	1
Neuroendocrine Tumors	1

Spanish Series of Patients Treated With the Radionuclide Lutetium177
NCT04949282 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · 20 locations

1 recruiting trial across 15 conditions.

No. For the full record, search ClinicalTrials.gov.